Analogously, PON2 knockdown and overexpression were induced in the T24 BC cell line and the data reported clearly demonstrated that the enzyme was able to promote bladder cancer cell viability, migration, and resistance to treatment with the chemotherapeutic drugs cisplatin and gemcitabine [32]. The gene discussed is PON2; the disease is urinary bladder carcinoma.